RECIST was developed in 2000 by the National Cancer Institute, European Organization for Research and Treatment of Cancer, and National Cancer Institute of Canada, with revision to RECIST 1.1 in 2009 ...

The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases, when the cancer remains localized to the prostate gland. But if the ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

Injecting poly-ICLC directly into prostate tumors before surgery may reawaken immune activity and help transform resistant ...

DEVELOPMENTS FROM THE NEWSROOM. DANNY AND SEAN, THIS IS BEING CHARACTERIZED AS AN AGGRESSIVE FORM OF PROSTATE CANCER, WHICH HAS SPREAD TO THE BONE. ACCORDING TO THE FORMER PRESIDENT’S OFFICE, HE WENT ...

Shocking health announcement coming from the Biden family. Former President Joe Biden diagnosed with an aggressive form of prostate cancer that has spread to his bones. His personal office releasing ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before the cancer comes back. Researchers at UCLA have found that a blend of a ...